1-4 of 4
Catherine Boyer
Close
Sort by
Journal Articles

Treatment of Von Willebrand Disease Women Undergoing Childbirth with a Von Willebrand Factor Product with a Low Content of Factor VIII: Results From 4 Multicenter Studies

Catherine Boyer-Neumann, Annie Borel-Derlon, MD, PhD, Jenny Goudemand, MD, PhD, Ségolène Claeyssens, Pierre-Marie Sie, MD, PhD, Philippe Moreau, Marie-Anne Bertrand, MD, Chantal Rothschild, MD, Benoît Guillet, MD, PhD, Jeanne Yvonne Borg, Catherine Chatelanaz, Wil Stevens, Françoise Bridey, Celine Henriet
Journal: Blood
Blood (2012) 120 (21): 3375.
https://doi.org/10.1182/blood.V120.21.3375.3375
Published: 2012
Journal Articles

Bim-EL, Is Sensitive to Proteasome Degradation and Contributes to Inducing Apoptosis after In Vitro Imatinib Mesylate Treatment of BCR-ABL Positive Cells.

Francis Belloc, PhD, Catherine Boyer, Francis Lacombe, MD, PhD, Vincent Praloran, MD, François-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4676.
https://doi.org/10.1182/blood.V104.11.4676.4676
Published: 2004
Journal Articles

The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A–like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor

Anne-Sophie Ribba, Lysiane Hilbert, Jean-Maurice Lavergne, Edith Fressinaud, Catherine Boyer-Neumann, Catherine Ternisien, Irène Juhan-Vague, Jenny Goudemand, Jean-Pierre Girma, Claudine Mazurier, Dominique Meyer
Journal: Blood
Blood (2001) 97 (4): 952–959.
https://doi.org/10.1182/blood.V97.4.952
Published: 2001
Journal Articles

Screening for von Willebrand Disease With a New Analyzer Using High Shear Stress: A Study of 60 Cases

Edith Fressinaud, Agnès Veyradier, Florence Truchaud, Isabelle Martin, Catherine Boyer-Neumann, Marc Trossaert, Dominique Meyer
Journal: Blood
Blood (1998) 91 (4): 1325–1331.
https://doi.org/10.1182/blood.V91.4.1325
Published: 1998